Effect of a tomato drink intervention on insulin-like growth factor (IGF)-1 serum levels in healthy subjects

Nutrition and Cancer

Volumn 55, Issue 2, 2006, Pages 157-162

  Riso, Patrizia ^a   Brusamolino, Antonella ^a   Martinetti, Antonia ^b   Porrini, Marisa ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; CAROTENOID; LYCOPENE; PHYTOENE; PHYTOFLUENE; PLACEBO; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CORRELATION ANALYSIS; DIETARY INTAKE; EVALUATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PROTEIN BLOOD LEVEL; TOMATO;

ADULT; ANTIOXIDANTS; BETA CAROTENE; BEVERAGES; CAROTENOIDS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LYCOPERSICON ESCULENTUM; MALE;

LYCOPERSICON ESCULENTUM;

EID: 33750851881     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5502_6     Document Type: Article

References (27)

1. Resnicoff M and Baserga R: The role of the insulin-like growth factor I receptor in transformation and apoptosis. Ann NY Acad Sci 842, 76-81, 1998.
2. Holly JMP, Gunnell DJ, and Davey Smith G: Growth hormone, IGF-1 and cancer: less intervention to avoid cancer? More intervention to prevent cancer? J Endocrinol 162, 321-330, 1999.
3. Yu H and Rohan T: Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92, 1472-1489, 2000.
4. Li L, Herbert Y, Schumacher F, Casey G, and Witte JS: Relation of serum insulin-like growth factor-1 (IGF-1) and IGF Binding protein-3 to risk of prostate cancer (United States). Cancer Causes and Control 14, 721-726, 2003.
5. Krajcik RA, Borofsky ND, Massardo S, and Orentreich N: Insulin-like growth factor1 (IGF-1), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev 11, 1361-1368, 2002.
6. Wakai K, Ito Y, Suzuki K, Tamakoshi A, Seki N, et al.: JACC Study Group Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) Study. JPN J Cancer Res 93, 1279-1286, 2002.
7. Mucci LA, Tamimi R, Lagiou P, Benetou V, Spanos E, et al.: Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int 87, 814-820, 2001.
8. Holmes MD, Pollak MN, Willett WC, and Hankinson SE: Dietary correlates of plasma insulin-like growth factor 1 and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11, 852-861, 2002.
9. Gunnell D, Oliver SE, Peters TJ, Donovan JL, Persad R, et al.: Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-1 and IGFBP-3 in healthy middle-aged men. Br J Cancer 88, 1682-1686, 2003.
10. Levy J, Bosin E, Feldman B, Giat Y, Miinster A, et al.: Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr Cancer 24, 257-266, 1995.
11. Karas M, Amir H, Fishman D, Danilenko M, Segal S, et al.: Lycopene interferes with cell cycle progression and insulin-like growth factor 1 signalling in mammary cancer cells. Nutr Cancer 36, 101-111, 2000.
12. Liu C, Lian F, Smith DE, Russell RM, and Wang XD: Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res 63, 3138-3144, 2003.
13. Wang S, DeGroff VL, and Clinton SK: Tomato and soy polyphenols reduce insulin-like growth factor-1-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signalling pathways involving tyrosine kinase. J Nutr 133, 2367-2376, 2003.
14. Voskuil DW, Vrieling A, van't Veer LJ, Kampman E, and Rookus MA: The insulin-like growth factor system in cancer prevention: potential of dietary intervention strategies. Cancer Epidemiol Biomarkers Prev 14, 195-203, 2005.
15. Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, et al.: Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 10, 861-868, 2001.
16. Porrini M, Riso P, Brusamolino A, Berti C, Guarnieri S, et al.: Daily intake of a formulated tomato drink affects carotenoid plasma and lymphocyte concentrations and improves cellular antioxidant protection. Brit J Nutr 93, 93-99, 2005.
17. Porrini M and Riso P: Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J Nutr 130, 189-192, 2000.
18. Riso P, Brusamolino A, Scalfi L, and Porrini M: Biavailability of carotenoids from spinach and tomatoes. Nutr Metab Cardiovasc Dis 14, 150-156, 2004.
19. Riso P, Visioli F, Erba D, Testolin G, and Porrini M: Lycopene and vitamin C concentrations increase in plasma and lymphocytes after tomato intake: effects on cellular antioxidant protection. Eur J Clin Nutr 58, 1350-1358, 2004.
20. Canene-Adams K, Campbell JK, Zaripheh S, Jeffery EH, and Erdman JW: The tomato as a functional food. J Nutr 135, 1226-1230, 2005.
21. Sharoni Y, Danilenko M, and Levy J: Molecular mechanisms for the anticancer activity of the carotenoid lycopene. Drug Dev Res 50, 448-456, 2000.
22. Wertz K, Siler U, and Goralczyk R: Lycopene: modes of action to promote prostate health. Arch Biochem Biophys 430, 127-134, 2004.
23. Thissen JP, Ketelslegers JM, and Underwood LE: Nutritional regulation of the insulin-like growth factors. Endocrine Rev 15, 80-101, 1994.
24. Woodside JV, Campbell MJ, Denholm EE, Newton L, Honour JW, et al.: Short-term phytoestrogen supplementation alters insulin-like growth factor profile but not lipid or antioxidant status. J Nutr Biochem 17, 211-215, 2006.
25. Gann PH, Kazer R, Chatterton R, Gapstur S, Thedford K, et al.: Sequential, randomized trial of low fat, high-fiber diet and soy supplementation: effects on circulating IGF-1 and its binding proteins in premenopausal women. Int J Cancer 116, 297-303, 2005.
26. Gunnell D, Oliver SE, Peters TJ, Donovan JL, Persad R, et al: Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-1 and IGFBP-3 in healthy middle-aged men. Br J Cancer 88, 1682-1686, 2003.
27. Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, Noord PAH, et al.: Dietary determinants of circulating insulin-like growth factor (IGF)-1 and IGF binding proteins 1, -2, and -3 in women in the Netherlands. Cancer Causes and Control 15, 787-796, 2004.